Nucleus RadioPharma Competitors and Similar CompaniesClear all
Nucleus RadioPharma's competitors and similar companies include RenovoRx, Rigenerand, Aktis Oncology and TScan Therapeutics.
 Nucleus RadioPharma Nucleus RadioPharma is a company specializing in radiopharmaceutical technology development, manufacturing, and supply chain. |  RenovoRx RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors. |  Rigenerand Rigenerand is a company offering products for clinical applications of cell-based technologies for regenerative medicine and oncology. |  Aktis Oncology Aktis Oncology (formerly known as HotKnot Therapeutics) is a biotechnology company that develops radiopharmaceuticals to treat a range of solid tumor cancers. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. | |
Founding Date | Founding Date 2022 | Founding Date 2012 | Founding Date 2009 | Founding Date 2020 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Rochester, US HQ | Locations Los Altos, US HQ | Locations Medolla, IT HQ | Locations Boston, US HQ Sacramento, US | Locations Waltham, US HQ |
Employees | Employees 432% increase | Employees 7 | Employees 5 | Employees 76 | Employees 7316% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 24.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 251.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $10.3m (FY, 2025) |
Net income | Net income N/A | Net income ($11.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($129.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 6m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 9.9m (about 10 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 6m | Total funding raised $ 10.2m | Total funding raised $ 9.9m | Total funding raised $ 72m | Total funding raised $ 137.5m |
For sources of this data, please see the company profile
View Company Profiles
RenovoRx
HQ
Los Altos, US
Employees
7
RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors.
View companyRigenerand
HQ
Medolla, IT
Employees
5
Rigenerand is a company offering products for clinical applications of cell-based technologies for regenerative medicine and oncology.
View companyAktis Oncology
HQ
Boston, US
Employees
76
Aktis Oncology (formerly known as HotKnot Therapeutics) is a biotechnology company that develops radiopharmaceuticals to treat a range of solid tumor cancers.
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View company